History
Sign in
Sign up
Molecular Cancer Therapeutics
IF
6.26
Papers
10.7k
Papers
10,000
1 page of 1,000 pages (10k results)
Newest
YES1: a novel therapeutic target and biomarker in cancer
Jun 23, 2022
·
Molecular Cancer Therapeutics
6.26
Impact Factor
Source
Cite
Save
Inhibition of mTORC1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma
Jun 23, 2022
·
Molecular Cancer Therapeutics
6.26
Impact Factor
Source
Cite
Save
Low-dose JAK3-inhibition improves anti-tumor T-cell immunity and immunotherapy efficacy
Jun 23, 2022
·
Molecular Cancer Therapeutics
6.26
Impact Factor
Source
Cite
Save
Inhibition of the translation initiation factor eIF4A enhances tumor cell radiosensitivity
Jun 23, 2022
·
Molecular Cancer Therapeutics
6.26
Impact Factor
Source
Cite
Save
Targeting therapeutic resistance and multinucleate giant cells in CCNE1-amplified HR-proficient ovarian cancer
Jun 23, 2022
·
Molecular Cancer Therapeutics
6.26
Impact Factor
Source
Cite
Save
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma.
Jun 16, 2022
·
Molecular Cancer Therapeutics
6.26
Impact Factor
Source
Cite
Save
1
2
3
4
5
6
7
8
9
10
Top fields of study
Cancer
Molecular biology
Chemistry
Immunology
Cancer research
Medicine
Biology
Cancer cell
Pharmacology
Feedback
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our
Privacy Policy.
Accept